Announcement of Cytokines 2023 Local Organizing Committee Member Irini Sereti as Chief of the combined LIR and LMM at NIH/NIAID

2nd from Right, LOC member Irini Sereti, MD, MHS; Left, Federica Sallusto, PhD; 2nd from Left, Co-Chair George Pavlakis, MD, PhD; Right, Chair, Evangelos Andreakos, PhD. Missing from photo, Athanasios Tzioufas, MD.

Dr Steven Holland, Scientific Director of NIAID announced announce the selection of Dr. Irini Sereti as the new Chief of the combined Laboratories of Immunoregulation (LIR), previously led by Dr Fauci, and Molecular Microbiology (LMM), led by Dr Malcolm Martin. Irini is currently Chief of the HIV Pathogenesis Section in the LIR, where she leads an innovative program on HIV pathogenesis and immune reconstitution. These now combined laboratories have largely defined and led the fields of HIV and AIDS research from the very beginning of the HIV pandemic. She was identified in a competitive national search.

Irini earned her M.D. from the National University of Athens School of Medicine in Greece and M.H.S. from Duke University. She did her Internal Medicine residency and Chief residency at Northwestern University in Chicago before doing her Infectious Diseases fellowship at NIAID. She received tenure in 2015. She is a physician scientist who has conducted multiple clinical trials and has published more than 200 peer reviewed papers. She is also a graduate of the Executive Leadership in Academic Medicine (ELAM) program and a member of the executive committees of the NIH Oxford-Cambridge Scholars Program and the Women Scientists Advisors (WSA). She is passionate about translational research with excellence in patient care, mentorship, and promotion of women in biomedical sciences. 

Dr. Sereti will assume her new duties in early 2024.